Chargement en cours...

Prostaglandin D(2): A dominant mediator of aspirin exacerbated respiratory disease

BACKGROUND: Aspirin desensitization followed by high-dose aspirin therapy is routinely performed for patients with aspirin exacerbated respiratory disease (AERD). Little is known about the contributions of mediators other than cysteinyl leukotrienes to aspirin reactions and to the therapeutic benefi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Allergy Clin Immunol
Auteurs principaux: Cahill, Katherine N., Bensko, Jillian C., Boyce, Joshua A., Laidlaw, Tanya M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289104/
https://ncbi.nlm.nih.gov/pubmed/25218285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2014.07.031
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!